Evidence map›Paper›PMID 25838403›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2015

Response to "clinical relevance of CYP3A5 genotype on maraviroc exposures".

Yanhui Lu, Edward J Fuchs, Craig W Hendrix, Namandjé N Bumpus

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yanhui LuDivision of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland.
Edward J FuchsDivision of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland.
Craig W HendrixDivision of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland.
Namandjé N BumpusDivision of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland nbumpus1@jhmi.edu.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Healthy VolunteersCyclohexanesCytochrome P-450 CYP3AHIV Fusion InhibitorsHumansTriazolesCyclohexanesCytochrome P-450 CYP3AHIV Fusion InhibitorsTriazoles

Identifiers

PMID25838403
PMCPMC4407709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.